Westwood Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Westwood Wealth Management's IBB Position: Q1 2026 in Review
Westwood Wealth Management opened a new position in iShares Biotechnology ETF (IBB) in Q1 2026: 5,100 shares worth $861K. The stake represents 0.34% of the portfolio and ranks #25 among its holdings. This is a return to the name: Westwood Wealth Management previously reported a position in IBB as recently as Q3 2025.
Westwood Wealth Management first reported a position in IBB in Q4 2021 and has held it in 17 quarters since. The position peaked at $4.42M in Q4 2021. 920 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Westwood Wealth Management held 5,100 shares of iShares Biotechnology ETF worth $861K as of Q1 2026.
- iShares Biotechnology ETF was a new Westwood Wealth Management position in Q1 2026.
- iShares Biotechnology ETF made up 0.34% of Westwood Wealth Management's portfolio in Q1 2026, its #25 holding.
- Westwood Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 17 quarters since.
- Westwood Wealth Management's iShares Biotechnology ETF position peaked at $4.42M in Q4 2021.
- 920 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Westwood Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.